Profit

JB Chemicals non-committal on dividend

PUBLISHED ON: May 24, 2011 | Duration: 6 min, 42 sec

  
loading..
JB Mody, CMD of JB Chemicals and Pharma says the company will lose 30 per cent of top line after the sale of its OTC brands in Russia and CIS countries to J&J subsidiary. The company will continue to look after the shareholders’ interests, the CMD assured.
ALSO WATCH
Sensex Gains Over 50 Points, Nifty Near 10,930

................................ Advertisement ................................

................................ Advertisement ................................